References
- Borges GM. Health transition in Brazil: regional variations and divergence/convergence in mortality. Cad Saúde Pública Internet. 2017 cited on May 25, 2018]. Available from 2018 May 25;33(8). http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2017000805001&lng=en&nrm=iso
- Schramm JMA, Oliveira AF, Leite IC, et al. Transição epidemiológica e o estudo de carga de doença no Brasil. Ciênc Saúde Colet Internet. 2004 cited on Sep 01, 2018]. Available from 2018 Sep 01;9(n. 4):897–908. http://www.scielo.br/pdf/csc/v9n4/a11v9n4.pdf.
- Daltio CS, Mari JJ, Ferraz MB. Estudos farmacoeconômicos e carga da doença em esquizofrenia. Rev Psiquiatr Clin. 2007 [cited on Sep 01, 2018]. Available from 2018 Sep 01];34(2): 208–212. Internet. http://www.scielo.br/pdf/rpc/v34s2/a12v34s2.pdf
- ONUBR. OMS registra aumento de casos de depressão em todo o mundo; no Brasil são 11,5 milhões de pessoas. [Internet] 2017 cited on Apr 08, 2018]. Available from 2018 Apr 08: https://www.paho.org/bra/index.php?option=com_content&view=article&id=5354:aumenta-o-numero-de-pessoas-com-depressao-no-mundo&Itemid=839
- OPAS. Depressão: o que você precisa saber. [Internet]. 2017 cited on Sep 03, 2018]. Available from 2018 Sep 03: https://www.paho.org/bra/index.php?option=com_content&view=article&id=5372:depressao-o-que-voce-precisa-saber&Itemid=822
- Citrome L, Jain R, Tung A, et al. Prevalence, treatment patterns, and stay characteristics associated with hospitalizations for major depressive disorder. J Affect Disord Internet. 2019 cited on Apr 18, 2022]. Available from 2022 Apr 18;249:378–384. https://www.sciencedirect.com/science/article/pii/S0165032718324728?via%3Dihub.
- Benson C, Singer D, Carpinella CM, et al. The health-related quality of life, work productivity, healthcare resource utilization, and economic burden associated with levels of suicidal ideation among patients self-reporting moderately severe or severe major depressive disorder in a national survey. Neuropsychiatr Dis Treat Internet]. 2021 cited on 2022 Apr 18;17:111–123. Available from. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822234/pdf/ndt-17-111.pdf
- De Berardis D, Olivieri L, Rapini G, et al. Religious coping, hopelessness, and suicide ideation in subjects with first-episode major depression: an exploratory study in the real world clinical practice Internet. Brain Sci. 2020 cited on Apr 18, 2022. 2022 Apr 18 10:912. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760269/pdf/brainsci-10-00912.pdf.
- Orsolini L, Latini R, Pompili M, et al. Understanding the complex of suicide in depression: from research to clinics. Psychiatry Investig. 2020;cited on Apr 18, 2022]. Available from 2022 Apr 18 17. 3:207–221. Internet: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113180/pdf/pi-2019-0171.pdf
- Leite IC, Valente JG, Schramm JMA, et al. Carga de doença no Brasil e suas regiões, 2008. Cad Saúde Pública Internet. 2015 cited on Mar 23, 2018]. Available from 2018 Mar 23;31(n. 7): 1551–1564. http://www.scielo.br/pdf/csp/v31n7/0102-311X-csp-31-7-1551.pdf
- WHO. Depression and other common mental disorders. Glo Health Esti. Internet. 2017 cited on 2018 Mar 23. Available from. https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng;jsessionid=48C79C7F85B4EAE3E08A8B93FA1216F6?sequence=1.
- BRASIL. Governo federal lança campanha de valorização da vida e de combate à depressão. [Internet]. Ministério da Saúde. 2019 cited on Apr 08, 2018]. Available from 2018 Apr 08. https://www.saude.gov.br/noticias/agencia-saude/45805-governo-federal-lanca-campanha-de-valorizacao-da-vida-e-de-combate-a-depressao
- Bacigalupe A, Martín U, Font R, et al. Austeridad y privatización sanitaria en época de crisis: ¿existen diferencias entre las comunidades autónomas? Gac Sanit Internet. 2016 cited on Jan 12, 2019]. Available from 2019 Jan 12;30(1):47–51. http://www.gacetasanitaria.org/es-pdf-S0213911115002071.
- Paes-Sousa R, Schramm JMDA, Mendes LVP. Fiscal austerity and the health sector: the cost of adjustments. Ciência & Saúde Coletiva Internet. 2019 [cited on 2021 May 26];24(12):4375–4384. Available from: https://www.scielo.br/j/csc/a/wJzqKMpydyJcqmjmxKz85Ww/?lang=en
- Elseviers M, Wettermark B, Almarsdóttir AB, et al. Drug utilization research: methods and applications. Canada Toronto: Wiley Blackwell; 2016.
- Wong J, Motulsky A, Abrahamowicz M, et al. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ. 2017;356:603. cited on May 06, 2022]. Available from 2022 May 06. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320934/.
- Dukes MNG. Drug Utilization Studies. Methods and Uses. Copenhagen: WHO Regional Publications/WHO Regional Office for Europe. European Series 45. 1993. [cited on 2021 May 26]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0011/156782/euro_series_45.pdf
- Cleare A, Pariante CM, Young AH, et al. Members of the consensus meeting. evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British association for psychopharmacology guidelines. J Psychopharmacol. 2015 May cited on May 05, 2021]. Available from 2021 May 05;29. 5:459–525. https://pubmed.ncbi.nlm.nih.gov/25969470/.
- American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry. 2000;1–45. cited on May 05, 2021]. Available from 2021 May 05: https://pubmed.ncbi.nlm.nih.gov/10767867/
- US Department of Health and Human Services. Depression Guideline Panel. Depression in primary care in clinical practice guideline number 5 Vol. 1. Rockville, Maryland, United States: J. Psychosoc. Nurs. Ment. Health Serv.;1993 cited on May 05, 2021]. Available from 2021 May 05. https://journals.healio.com/doi/10.3928/0279-3695-19930601-12
- Rutz W, von Knorring L, Walinder J. Long-term effects of an educational program for general practitioners given by the Swedish committee for the prevention and treatment of depression. Acta Psychiatr Scand. 1992;85. 1:83–88. cited on May 05, 2021]. Available from 2021 May 05. https://pubmed.ncbi.nlm.nih.gov/1546555/
- Fleck MP, Berlim MT, Lafer B, et al. Revisão das diretrizes da Associação Médica Brasileira para o tratamento da depressão. Versão integral. Rev Bras Psiquiatr São Paulo. 2009;31(1):S7–S17. cited on Jan 21, 2019]. Available from 2019 Jan 21 http://www.scielo.br/pdf/rbp/v31s1/a03v31s1.pdf.
- Antunes JLF, Cardoso MRA. Uso da análise de séries temporais em estudos epidemiológicos. Epidemiol Serv Saúde. 2015 [cited on May 25, 2018]. Available from 2018 May 25];24(n. 3): 565–576. Internet. http://www.scielo.br/pdf/ress/v24n3/2237-9622-ress-24-03-00565.pdf
- McCarter T. Depression overview. Am Health Drug Benefits. cited on May 05, 2021]. Available from 2021 May 05 2008;13:44–51. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115320/
- Stark P, Hardison CD. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. 1985. J Clin Psychiatry. cited on May 05, 2021]. Available from 2021 May 05; 46(3):53–58. Sect 2. https://psycnet.apa.org/record/1986-07250-001
- Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr. 2002 Apr cited on May 05, 2021]. Available from 2021 May 05;7(4 Suppl 1):40–44. https://pubmed.ncbi.nlm.nih.gov/15131492/
- Ropert R, Bouchard JM, Caroli F, et al. Fluoxetine versus clomipramine in major depressive disorders. Int Clin Psychopharmacol. 1989;4(Suppl 1):89–95. cited on May 05, 2021]. Available from 2021 May 05 https://psycnet.apa.org/record/1989-30506-001.
- Pinder RM, Brogden RN, Speight TM, et al. Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs. 1977May cited on May 05, 2021]. Available from 2021 May 05;13. 5:321–352. https://pubmed.ncbi.nlm.nih.gov/326531/
- Wheatley DP, van Moffaert M, Timmerman L, et al. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine study group. J Clin Psychiatry. 1998Jun cited on May 05, 2021]. Available from 2021 May 05;59. 6:306–312. https://pubmed.ncbi.nlm.nih.gov/9671343/
- Hashemi S, Shirazi HG, Mohammadi A, et al. Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial. Clin Pharmacol. 2012;4:1–6. cited on May 05, 2021]. Available from 2021 May 05 https://pubmed.ncbi.nlm.nih.gov/22359466/
- McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry. 2006Sep cited on May 05, 2021]. Available from 2021 May 05;163. 9:1531–1541. https://pubmed.ncbi.nlm.nih.gov/16946177/
- Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo J Clin Psychiatry 2001Nov 62. 11 869–877 cited on May 05, 2021]. Available from 2021 May 05https://pubmed.ncbi.nlm.nih.gov/11775046/
- WHOCC. ATC/DDD index 2019. [Internet] 2019 [cited on 2019 Jan 12]. Available from: https://www.whocc.no/atc_ddd_index/
- ANVISA. Sistema Nacional de Gerenciamento de Produtos Controlados (SNGPC). [Internet] 2018 cited on Oct 24, 2018]. Available from 2018 Oct 24: http://portal.anvisa.gov.br/sngpc
- IBGE. System of quarterly national accounts - SCNT. Historical series. 2019. cited on May 30, 2021]. Available from 2021 May 30: https://www.ibge.gov.br/estatisticas/economicas/contas-nacionais/9300-contas-nacionais-trimestrais.html?=&t=series-historicas&utm_source=landing&utm_medium=explica&utm_campaign=pib#evolucao-pib
- BRAZIL. Department of treasury. Annual Debt Report. cited on May 30, 2021]. Available from 2021 May 30: http://www.tesouro.fazenda.gov.br/web/stn/-/relatorio-anual-da-divida
- Central Bank of Brazil. Net savings report. 2019. [cited on 2021 May 30]. Available from: https://www.bcb.gov.br/estabilidadefinanceira/relatoriopoupanca
- Zhao LH, Wei WQ, Ma HM, et al. Analysis of mortality and years of life lost of malignant tumors among inhabitants in rural area of Feicheng city from 2000 to 2010. Zhonghua Zhong Liu Za Zhi. 2013 Sep cited on Apr 19, 2022]. Available from 2022 Apr 19;35(9):714–719. https://pubmed.ncbi.nlm.nih.gov/24332062/.
- R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. [Internet] 2019 cited on Oct 16, 2019]. Available from 2019 Oct 16: https://www.R-project.org/
- R Core Team. foreign: read data stored by ‘minitab,’ ‘S,’ ‘SAS,’ ‘SPSS,’ ‘Stata,’ ‘Systat,’ ‘Weka,’ ‘dBase.’ R package version 0.8-71. [Internet] 2018 cited on Oct 16, 2019]. Available from 2019 Oct 16: https://CRAN.R-project.org/package=foreign
- Wickham H, Bryan J. readxl: read excel files. R package version 1.3.1. [Internet] 2019 cited on Oct 16, 2019]. Available from 2019 Oct 16: https://CRAN.R-project.org/package=readxl
- Trapletti A, Hornik K. tseries: time series analysis and computational finance. R package version 0.10-47. [Internet] 2019 cited on Oct 16, 2019]. Available from 2019 Oct 16: https://rdrr.io/cran/tseries/
- Mohr FX. prais: Prais-Winsten Estimator for AR(1) serial correlation. R package version 1.1.1. [Internet] 2019 cited on Oct 16, 2019]. Available from 2019 Oct 16: https://CRAN.R-project.org/package=prais
- Prais SJ, Winsten CB. Trend estimators and serial correlation. Working paper 383, Cowles Commission, 1954. cited on Apr 19, 2022]. Available from 2022 Apr 19: http://cowles.yale.edu/sites/default/files/files/pub/cdp/s-0383.pdf
- Tsay RS. Multivariate time series analysis with R and financial applications. Hoboken New Jersey: John Wiley & Sons; 2013.
- Durbin J, Watson GS. Testing for serial correlation in least squares regression: i. Biometrika. 1950 Dec;37(3–4):409–428.
- Dickey DA, Fuller WA. Distribution of the estimators for autoregressive time series with a unit root. J Am Stat Assoc. 1979;74(366):427–431. cited on Apr 19, 2022]. Available from 2022 Apr 19 https://www.academia.edu/22511940/Distribution_of_the_Estimators_for_Autoregressive_Time_Series_with_a_Unit_Root.
- Onocko-Campos RT. Mental health in Brazil: strides, setbacks, and challenges. Cad Saúde Pública [online]. 2019 cited on 2022 May 06;35(n.11). Available from. http://old.scielo.br/pdf/csp/v35n11/en_1678-4464-csp-35-11-e00156119.pdf
- Vieira FS, Santos MABD. O setor farmacêutico no Brasil sob as lentes da conta-satélite de saúde. IPEA. 2020 cited on May 06, 2022]. Available from 2022 May 06;n. 2615:1–74 Brasília/Rio de Janeiro, texto para discussãohttps://www.ipea.gov.br/portal/images/stories/PDFs/TDs/td_2615.pdf
- Grigorakis N, Floros C, Tsangari H, et al. Out of pocket payments and social health insurance for private hospital care: evidence from Greece. Health Policy. 2016 cited on Dec 06, 2019]. Available from 2019 Dec 06;120(8):948–959. Internet: https://www.sciencedirect.com/science/article/pii/S0168851016301713?via%3Dihub
- Sicras-Mainar A, Navarro-Artieda R. Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisis. Neuropsychiatr Dis Treat. 2015 [cited on Dec 13, 2019]. Available from 2019 Dec 13];12:29–40. Internet: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699544/
- Casciano VL. Patentes e genéricos: barreiras e oportunidades para o acesso a medicamentos no mercado brasileiro. 2011. 65 p. Term paper (Postgraduation course)- Pharmaceuticals Technology Institute/Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, 2011
- BRASIL. Relação Nacional de Medicamentos Essenciais 2020. [Internet]. Ministério da Saúde. 2020. cited on Aug 01, 2020]. Available from 2020 Aug 01: https://bvsms.saude.gov.br/bvs/publicacoes/relacao_medicamentos_rename_2020.pdf
- Prado MAMB, Francisco PMSB, Barros MBA. Uso de medicamentos psicotrópicos em adultos e idosos residentes em Campinas, São Paulo: um estudo transversal de base populacional. Epidemiol Serv Saúde. 2017 [cited on Dec 15, 2019]. Available from 2019 Dec 15];26(n. 4):747–758. Internet: http://www.scielo.br/pdf/ress/v26n4/2237-9622-ress-26-04-00747.pdf
- Chu A, Wadhwa R. Selective serotonin reuptake inhibitors. StatPearls [Internet]. 2020 cited on Jul 07, 2020]. Available from 2020 Jul 07: https://www.ncbi.nlm.nih.gov/books/NBK554406/
- Carlini EA, Noto AR, Nappo SA, et al. Fluoxetina: indícios de uso inadequado. J Bras Psiquiatr. 2009 cited on Jul 13, 2020]. Available from 2020 Jul 13;58(n. 2):97–100. Internet: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852009000200005&lng=en&nrm=iso
- Lewis-Hall FC, Wilson MG, Tepner RG, et al. Fluoxetine vs. tricyclic antidepressants in women with major depressive disorder. J Women Health. 1997;cited on Sep 01, 2020]. Available from 2020 Sep 01: 6:337–343. Internet https://www.liebertpub.com/doi/pdfplus/10.1089/jwh.1997.6.337
- Sundell KA, Gissler M, Petzold M, et al. Antidepressant utilization patterns and mortality in Swedish men and women aged 20-34 years. Eur J Clin Pharmacol. 2011;cited on Aug 05, 2020]. Available from 2020 Aug 05: 67. 2:169–178. Internet https://link.springer.com/article/10.1007/s00228-010-0933-z
- Mota DM, Silva-Jr GG. Evidências advindas do consumo de medicamentos moduladores do apetite no Brasil: um estudo farmacoeconométrico. Rev Assoc Med Bras. 2012;58(n. 1):88–94. [cited on Sep 02, 2020]. Available from 2020 Sep 02]. Internet: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302012000100020&lng=en&nrm=iso
- Machado AV. O uso de fluoxetina e fatores associados: estudo populacional. 70 p. [dissertation; Internet]. University of Brasília. 2018 cited on Dec 06, 2019]. Available from 2019 Dec 06: https://repositorio.unb.br/handle/10482/32076
- García-Azorin D, Santos-Lasaosa S, Gago-Veiga AB, et al. Real world preventative drug management of migraine among Spanish neurologists. J Headache Pain Internet]. 2019 Feb 15;20:19. [cited on Apr 18, 2022]. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734505/pdf/10194_2019_Article_971.pdf.
- Attal N. Pharmacological treatments of neuropathic pain: the latest recommendations. Rev Neurol (Paris). 2019 Jan-Feb [cited on Apr 18, 2022]. Available from 2022 Apr 18];175. 1-2:46–50. Internet:https://www.em-consulte.com/article/1276018/alertePM
- Hartmann PM. Mirtazapine: a newer antidepressant. Am Fam Physician. Internet]. 1999 Jan 1;59:159–161. [cited on Apr 18, 2022]. Available fromhttps://www.aafp.org/afp/1999/0101/p159.html
- Frieling H, Bleich S. Tranylcypromine: new perspectives on an “old” drug. Eur Arch Psychiatry Clin Neurosci. 2006 [cited on Dec 08, 2019]. Available from 2019 Dec 08];256. 5:268–273. Internet: https://www.ncbi.nlm.nih.gov/pubmed/16927039
- Sainz de Rozas Aparicio C, Ruiz Clavijo Díez MT, Díaz Madero A. Evolución del consumo de fármacos antidepresivos en las áreas sanitarias de la Rioja y Zamora durante el período 1997-2001. Rev Esp Salud Publica. 2004 [cited on Dec 15, 2019]. Available from 2019 Dec 15];78(n. 5):631–645. Internet: http://scielo.isciii.es/pdf/resp/v78n5/original6.pdf
- Bryson HM, Wilde MI. Amitriptyline A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging. 1996 [cited on Dec 08, 2019]. Available from 2019 Dec 08];8(6):459–476. Internet: https://www.ncbi.nlm.nih.gov/pubmed/8736630
- Lawson K. A brief review of the pharmacology of amitriptyline and clinical outcomes in treating fibromyalgia. Biomedicines. 2017 [cited on Dec 08, 2019]. Available from 2019 Dec 08];5(2):24. Internet: https://www.ncbi.nlm.nih.gov/pubmed/28536367
- Dunlap L, Han B, Dowd WN, et al. Behavioral health outcomes among adults: associations with individual and community-level economic conditions. Psychiatric Serv. 2016;cited on Jul 17, 2020]. Available from 2020 Jul 17: 67:71–77. Internet https://ps.psychiatryonline.org/doi/full/10.1176/appi.ps.201400016
- Zivin K, Paczkowski M, Galea S. Economic downturns and population mental health: research findings, gaps, challenges and priorities. Psychol Med. 2011 [cited on Jul 17, 2020]. Available from 2020 Jul 17];41(7):1343–1348. Internet: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846090/pdf/nihms529057.pdf
- Jirón M, Machado M, Ruiz I. Consumption of antidepressants in Chile from 1992 to 2004. Rev Med Chil. 2008 [cited on Dec 06, 2019]. Available from 2019 Dec 06];136:1147–1154. Internet: https://www.ncbi.nlm.nih.gov/pubmed/19030659